NCT01667419 · Interventional trial
A Study of Vemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant Melanoma
Overall registry status Completed
Phase 3
Conditions Melanoma
Delaware Valley sites
- University of Pennsylvania Health System · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory